# Comparing the test performance of dried-blood-spot and plasma HIV recent infection testing samples in a nationally scaled sex worker programme in Zimbabwe

**Authors:** Brian D. Rice, Harriet S. Jones, Fortunate Machingura, Leah Gaihai, Memory Makamba, Thomas Chanyowedza, Panganai Masvikeni, Edward Matsikire, Primrose Matambanadzo, Sithembile Musemburi, Phillip N. Chida, Jeffery Dirawo, Owen Mugurungi, Sarah Bourdin, James R. Hargreaves, Gary Murphy, Frances M. Cowan, Helen Howard, Muki Shey, Muki Shey, Muki Shey

PMC · DOI: 10.1371/journal.pgph.0003791 · PLOS Global Public Health · 2025-11-05

## TL;DR

This study compares dried-blood-spot and plasma samples for HIV recency testing among sex workers in Zimbabwe to assess test performance and potential biases.

## Contribution

The study provides empirical evidence on the performance differences between DBS and plasma samples in HIV recency testing at a national scale.

## Key findings

- 97% of results from dried-blood-spot and plasma samples were concordant in classifying recent HIV infections.
- Plasma samples had a higher normalized optical density than DBS samples, with a mean difference of 0.53.
- 12 out of 58 paired samples showed discordance, with most classified as recent by DBS but long-standing by plasma.

## Abstract

Recency testing can provide strategic insights as to whether a person newly diagnosed with HIV recently acquired their infection or not. To understand potential biases associated with HIV recency testing, we explored the extent sample type influences whether a person is assigned as being recent. Implementing a laboratory-based Recent Infection Testing Algorithm (RITA) across the Centre for Sexual Health and HIV/AIDS Research (CeSHHAR) key populations programme in Zimbabwe between October 2021 and January 2023, we compared plasma-based and dried-bloodspot (DBS) HIV recency samples. Over the study period, 24,976 individual female sex workers HIV tested, of whom 9.5% (2,363/24,979) newly tested HIV positive. Of these 2,363 women, 55.5% (1311/2,363) were offered and gave consent for a sample to be taken for DBS recency and viral load testing, among whom 11.7% (153/1,311) were classified as having a recent infection. A subset of 464 women were offered and consented to paired sample collection, among whom 10.1% (47) and 12.3% (57) of plasma and DBS samples, respectively, were classified as recent. Overall, categorical determination was good, with 97% of results concordant. Of 58 women with paired sample collection who had a test result classified as recent, 46 (79.3%) were concordant recent on both DBS and plasma, with 12 (20.7%) being discordant. Of these 12 women’s samples, 11 were deemed long-standing by the plasma assay but recent by the paired DBS, and one deemed long-standing by DBS but recent by the paired plasma sample. On average, plasma samples had a higher normalised optical density than DBS samples (mean difference of 0.53). Depending on use-case and setting, there are trade-offs when considering DBS or plasma-based samples between test performance and ease of implementation. Our data can help inform statistical adjustments to harmonise cut-offs on DBS and plasma assays, thereby improving the use and interpretation of recency assays in population-level HIV surveillance activities.

## Full-text entities

- **Diseases:** HIV (MESH:D015658), Infection (MESH:D007239)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12588490/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12588490/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC12588490/full.md

---
Source: https://tomesphere.com/paper/PMC12588490